Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

Josef S. Smolen, Jonathan Kay, Mittie K. Doyle, Robert Landewé, Eric L. Matteson, Jürgen Wollenhaupt, Norman Gaylis, Frederick T. Murphy, Jeffrey S. Neal, Yiying Zhou, Sudha Visvanathan, Elizabeth C. Hsia, Mahboob U. Rahman

Research output: Contribution to journal › Article › peer-review

415 Scopus citations

Fingerprint

Dive into the research topics of 'Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial'. Together they form a unique fingerprint.

Medicine & Life Sciences